Evaluation of the therapeutic and preventive efficacy of 2.5 % moxidectin / 10 % imidacloprid (Advocate(®), Bayer animal health) in dogs naturally infected or at risk of natural infection by Dirofilaria repens. (Q52724209)
Jump to navigation
Jump to search
scientific article published in August 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluation of the therapeutic and preventive efficacy of 2.5 % moxidectin / 10 % imidacloprid (Advocate(®), Bayer animal health) in dogs naturally infected or at risk of natural infection by Dirofilaria repens. |
scientific article published in August 2011 |
Statements
Evaluation of the therapeutic and preventive efficacy of 2.5 % moxidectin / 10 % imidacloprid (Advocate(®), Bayer animal health) in dogs naturally infected or at risk of natural infection by Dirofilaria repens. (English)
1 reference
Klaus Hellmann
1 reference
Josef Heine
1 reference
Gabriele Braun
1 reference
Radmila Paran-Dobesova
1 reference
Vlasta Svobodova
1 reference
1 August 2011
1 reference
109 Suppl 1
1 reference
S77-86
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference